Boston Scientific announces positive results from its Champion-Af study
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
The study evaluated the performance of the Watchman Flx™ left atrial appendage occluder as a first-line therapy for reducing stroke risk. Research data show that the Watchman Flx™ device met all predefined primary safety endpoints and primary efficacy endpoints. At the same time, all secondary safety and efficacy endpoints were also successfully achieved. These results indicate that, as a first-line therapy, the device demonstrates excellent safety and efficacy, offering an important new option for stroke prevention.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Brazil signs anti-gang bill allowing confiscated cryptocurrencies to fund law enforcement agencies
Odaily星球日报•2026/03/28 15:34
Trending news
MoreCrypto prices
MoreBitcoin
BTC
$66,862.11
+1.17%
Ethereum
ETH
$2,022.68
+1.73%
Tether USDt
USDT
$0.9993
+0.00%
BNB
BNB
$616.4
+1.17%
XRP
XRP
$1.35
+1.25%
USDC
USDC
$0.9998
+0.01%
Solana
SOL
$83.62
+0.75%
TRON
TRX
$0.3160
+2.48%
Dogecoin
DOGE
$0.09316
+3.27%
Hyperliquid
HYPE
$39.9
+3.76%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now